Last reviewed · How we verify
Infection due to anaerobic bacteria
Approved treatments
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage. - Metro I.V. In Plastic Container · Baxter
- Metronidazol · University of Oslo
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Infection due to anaerobic bacteria patent landscape — cliff calendar, originator estates, attackable patents
- Infection due to anaerobic bacteria treatment landscape brief
- Infection due to anaerobic bacteria treatment updates RSS
Frequently asked questions about Infection due to anaerobic bacteria
What drugs treat Infection due to anaerobic bacteria?
Tracked treatments include Cleocin T, Cleocin, Metro I.V. In Plastic Container, Metronidazol.
What is the treatment for Infection due to anaerobic bacteria?
Standard treatment for Infection due to anaerobic bacteria includes Cleocin T, Cleocin, Metro I.V. In Plastic Container, Metronidazol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Infection due to anaerobic bacteria patent cliff · Infection due to anaerobic bacteria CI report
- Treatment: Cleocin T · Pfizer
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- Treatment: Metro I.V. In Plastic Container · Baxter
- Treatment: Metronidazol · University of Oslo
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing